Dianthus Therapeutics, Inc. /DE/ ($DNTH)
Filing Information
| Accession Number | 0001992324-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 13, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
93,747
Total Value
$3,837,441.59
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, CFO & CBO | Common Stock | โ | Jul 9, 2026 | Exercise/Conversion | 31,249 | $21.77 | $680,290.73 | 31,249 | Direct | โ | View Details | |
EVP, CFO & CBO | Common Stock | โ | Jul 9, 2026 | Sale | 10,354 | $100.22 | $1,037,677.88 | 20,895 | Direct | โ | View Details | |
EVP, CFO & CBO | Common Stock | โ | Jul 9, 2026 | Sale | 15,329 | $101.24 | $1,551,907.96 | 5,566 | Direct | โ | View Details | |
EVP, CFO & CBO | Common Stock | โ | Jul 9, 2026 | Sale | 5,566 | $101.97 | $567,565.02 | 0 | Direct | โ | View Details | |
EVP, CFO & CBO | Stock Option (Right to Buy) | Derivative | Jul 9, 2026 | Exercise/Conversion | 31,249 | $0.00 | $0.00 | 68,751 | Direct | โ | View Details |